Tirzepatide — sold under the brand names Mounjaro and Zepbound — has become one of the most prescribed drugs in America. Marketed for type 2 diabetes and weight loss, it has helped millions of patients. But a growing wave of lawsuits alleges that the drug's manufacturer, Eli Lilly, failed to adequately warn patients and doctors about severe gastrointestinal side effects, including gastroparesis (stomach paralysis), intestinal blockage, and pancreatitis. If you or a loved one suffered serious harm after taking tirzepatide, you may be entitled to compensation. This guide explains the lawsuits, who qualifies, what compensation is available, and how to file a claim in 2026.
What Is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist — the first drug in its class to target two gut hormones at once. It works by slowing gastric emptying, increasing insulin production, reducing appetite, and promoting a feeling of fullness. The FDA approved tirzepatide under the brand name Mounjaro in May 2022 for type 2 diabetes, and under the brand name Zepbound in November 2023 for chronic weight management in adults with obesity or overweight with weight-related conditions.
The drug is administered as a once-weekly injection. Clinical trials showed impressive results: patients lost an average of 15% to 22% of their body weight over 72 weeks, and many saw significant improvements in blood sugar control. Those results made tirzepatide a blockbuster — with prescriptions surging into the millions within two years of approval.
But the same mechanism that makes tirzepatide effective — slowing the digestive system — is at the heart of the lawsuits. Plaintiffs allege that the drug's label understated the severity and persistence of gastrointestinal side effects, and that Eli Lilly knew or should have known that some patients would develop serious, sometimes permanent, digestive injuries.
The Tirzepatide Lawsuits
Tirzepatide lawsuits are part of the broader GLP-1 litigation that has grown rapidly since 2023. Lawsuits involving tirzepatide, semaglutide (Ozempic, Wegovy, Rybelsus), and other GLP-1 drugs have been consolidated into a federal multidistrict litigation (MDL) — In re: GLP-1 Receptor Agonists Products Liability Litigation, MDL No. 3094, in the Eastern District of Pennsylvania. Consolidation into an MDL streamlines pretrial proceedings, including discovery and expert testimony, while each plaintiff's case remains individual.
The core allegations in tirzepatide lawsuits include:
- Failure to warn: Plaintiffs allege Eli Lilly failed to adequately warn patients and prescribing physicians that tirzepatide could cause gastroparesis, intestinal blockage (ileus), severe vomiting, pancreatitis, gallbladder disease, and vision loss. The original label listed nausea, vomiting, diarrhea, and constipation as common side effects but allegedly did not convey that these symptoms could signal serious, long-lasting digestive injury.
- Defective design: Some lawsuits allege that tirzepatide's risks outweigh its benefits for certain patients, or that a safer alternative design — such as a lower starting dose, a slower titration schedule, or additional monitoring — could have reduced the risk of severe harm.
- Negligent marketing: Plaintiffs allege that aggressive direct-to-consumer advertising and promotion of tirzepatide for weight loss downplayed the drug's risks and encouraged use by patients who might not have fully understood the potential side effects.
- Post-marketing surveillance failures: Lawsuits allege that Eli Lilly did not act quickly enough on mounting adverse event reports after the drug reached the market.
Eli Lilly has denied wrongdoing and maintains that tirzepatide's label accurately reflects the drug's known risks. The company notes that gastrointestinal side effects are listed in the prescribing information and that the benefits of the drug for diabetes and obesity are substantial. As with any litigation, the outcome of individual cases will depend on the specific facts, medical evidence, and applicable law.
Serious Side Effects Linked to Tirzepatide
Most patients who take tirzepatide experience only mild to moderate side effects that resolve over time. The lawsuits focus on severe side effects that allegedly caused lasting harm:
1. Gastroparesis (Stomach Paralysis)
Gastroparesis occurs when the stomach muscles slow down or stop working, so food sits in the stomach far longer than normal. Symptoms include severe nausea, vomiting undigested food hours after eating, bloating, abdominal pain, loss of appetite, and unintended weight loss. In severe cases, gastroparesis can lead to dehydration, malnutrition, dangerously low blood sugar, and bezoars (hardened masses of undigested food). Diagnosis typically requires a gastric emptying study. Some patients allege their gastroparesis persisted long after they stopped taking tirzepatide.
2. Intestinal Blockage (Ileus)
Ileus is a temporary or prolonged halt in the normal movement of the intestines. Symptoms include severe abdominal pain, bloating, constipation, inability to pass gas, vomiting, and loss of appetite. Complete intestinal blockage is a medical emergency that may require hospitalization, nasogastric decompression, or surgery. Plaintiffs allege that tirzepatide's slowing of the digestive tract contributed to dangerous blockages.
3. Pancreatitis
Pancreatitis — inflammation of the pancreas — is a serious condition that can cause severe upper abdominal pain, nausea, vomiting, fever, and rapid pulse. Acute pancreatitis may require hospitalization, and chronic or necrotizing pancreatitis can cause permanent damage. The tirzepatide label includes a warning about pancreatitis, but lawsuits allege the warning was insufficient given the severity of the risk.
4. Gallbladder Disease
Rapid weight loss is itself a risk factor for gallstones, and GLP-1 drugs have been linked to gallbladder problems, including gallstones, cholecystitis (gallbladder inflammation), and the need for gallbladder removal surgery (cholecystectomy). Symptoms include sudden pain in the upper right abdomen, pain radiating to the shoulder, nausea, vomiting, and fever.
5. Vision Loss (NAION)
Non-arteritic anterior ischemic optic neuropathy (NAION) is a rare but serious eye condition that can cause sudden, permanent vision loss. A 2024 study published in JAMA Ophthalmology found an association between semaglutide use and NAION, prompting further scrutiny of the entire GLP-1 class, including tirzepatide. Research is ongoing, and no causal link has been definitively established for tirzepatide specifically.
6. Severe Dehydration and Malnutrition
Persistent vomiting, diarrhea, and loss of appetite can lead to dehydration, electrolyte imbalances, kidney injury, and malnutrition — particularly in older adults or patients with pre-existing kidney disease. Some lawsuits allege that patients required emergency treatment or hospitalization for dehydration-related complications.
If you experienced any of these conditions after taking tirzepatide, seek medical attention promptly and keep detailed records of your symptoms, diagnosis, and treatment.
Who Qualifies for a Tirzepatide Lawsuit?
You may qualify to file a tirzepatide lawsuit if you meet the following criteria:
- You took tirzepatide (Mounjaro or Zepbound) as prescribed by a doctor.
- You were diagnosed with a serious side effect such as gastroparesis, intestinal blockage, pancreatitis, gallbladder disease requiring surgery, or vision loss after starting the drug.
- Your injury required medical treatment — hospitalization, emergency care, surgery, ongoing medication, or long-term monitoring.
- Your injury occurred within the statute of limitations in your state (see below).
- You can document your use of the drug and your injury through medical records, pharmacy records, and prescribing information.
Family members may be able to file a wrongful death claim if a loved one died from complications allegedly linked to tirzepatide. An attorney can evaluate whether your specific circumstances support a claim, even if your side effect is not listed above.
Compensation Available in Tirzepatide Lawsuits
Compensation in pharmaceutical lawsuits typically falls into several categories:
- Medical expenses: Past and future costs of hospitalization, surgery, diagnostic testing, medications, specialist visits, and ongoing care.
- Lost wages: Income lost while recovering, plus reduced earning capacity if the injury caused long-term disability.
- Pain and suffering: Physical pain, emotional distress, anxiety, depression, and loss of enjoyment of life.
- Out-of-pocket costs: Travel to medical appointments, home care, dietary modifications, and other expenses caused by the injury.
- Punitive damages: In rare cases, courts may award punitive damages if the manufacturer is found to have acted with reckless disregard for patient safety. Punitive damages are intended to punish and deter misconduct, not merely to compensate the plaintiff.
- Wrongful death damages: Funeral expenses, loss of financial support, and loss of companionship for surviving family members.
Settlement Values in 2026
It is impossible to predict the exact value of any individual case, and no attorney can guarantee a specific outcome. However, based on comparable pharmaceutical mass tort litigation, potential settlement values are often discussed in tiers:
- Lower tier: Patients with moderate injuries that resolved with treatment and limited medical expenses may see settlements in the tens of thousands of dollars.
- Middle tier: Patients who required hospitalization, surgery, or extended treatment may see settlements in the range of $100,000 to $400,000, depending on the severity and duration of the injury.
- Upper tier: Patients with permanent injuries, multiple surgeries, or life-altering complications may see settlements of $500,000 or more.
These figures are illustrative estimates based on patterns in similar litigation, not guarantees. Your case value depends on the strength of the evidence linking tirzepatide to your injury, the severity and permanence of your harm, your medical costs and lost income, and the law in your state.
Lawsuit vs. Class Action vs. MDL
Many people confuse these three legal structures. Understanding the difference matters:
- Individual lawsuit: You file your own case. Your damages are evaluated individually, and any settlement or verdict is based on your specific injuries.
- Class action: A single lawsuit represents a large group of people with similar claims. Class members typically share a single settlement, divided among them. Class actions are less common in pharmaceutical injury cases because injuries vary widely from person to person.
- Multidistrict litigation (MDL): Individual lawsuits are consolidated before one federal judge for pretrial proceedings (discovery, expert testimony, bellwether trials), but each case remains separate. If cases do not settle, they are remanded to their original courts for trial. Most large pharmaceutical litigations, including the GLP-1 litigation, proceed as an MDL.
Tirzepatide cases are being handled primarily through the GLP-1 MDL. Joining the MDL does not mean you give up control of your case — you retain your own attorney, and your settlement (if any) is based on your individual circumstances.
How to File a Tirzepatide Lawsuit: 7 Steps
- Seek medical care and document everything. See a doctor promptly for your symptoms. Keep copies of all medical records, diagnoses, prescriptions, and treatment plans. Note when symptoms began relative to when you started tirzepatide.
- Preserve evidence of your tirzepatide use. Save pharmacy records, prescription bottles, injection pens, receipts, and any communications with your doctor or pharmacist about the drug. Do not discard medication packaging.
- Do not stop taking tirzepatide without talking to your doctor. Stopping abruptly can affect blood sugar control and overall health. Discuss any concerns with your prescribing physician before making changes to your medication.
- Contact a tirzepatide lawyer for a free case evaluation. Most pharmaceutical injury attorneys offer free consultations and work on a contingency fee basis (see below). An attorney can review your medical records and advise whether you have a viable claim.
- Your attorney gathers evidence. Your lawyer will collect medical records, pharmacy records, expert medical opinions, and evidence about Eli Lilly's warnings and marketing. This is the discovery phase of the case.
- Your case joins the MDL (if applicable). Your attorney will file your case in federal court, where it may be transferred to the GLP-1 MDL for coordinated pretrial proceedings.
- Settlement negotiations or trial. Most pharmaceutical cases settle before trial, often after bellwether trials establish the range of potential verdicts. If your case does not settle, it may proceed to trial, where a jury decides liability and damages.
Statute of Limitations
The statute of limitations — the deadline for filing a lawsuit — varies by state, typically from 1 to 6 years for personal injury claims. In many states, the clock starts when you knew or reasonably should have known that tirzepatide caused your injury (the "discovery rule"), not necessarily when you took the drug. Because these deadlines are strict and missing them can permanently bar your claim, contact an attorney as soon as possible after a diagnosis. Do not wait to see how the MDL unfolds — your individual deadline may arrive sooner than you expect.
Lawyer Costs: Contingency Fees
Most tirzepatide lawyers work on a contingency fee basis. That means:
- No upfront cost. You pay nothing to hire the attorney or file your case.
- The attorney is paid only if you win. The fee is typically 33% to 40% of your settlement or verdict, plus case expenses (medical record retrieval, expert witnesses, filing fees).
- If you lose, you generally owe no attorney's fee (though you may still be responsible for certain costs, depending on your agreement).
Before signing, ask your attorney to explain the fee agreement in writing, including how expenses are handled and what percentage applies if the case settles versus going to trial.
Choosing the Right Tirzepatide Lawyer
- Mass tort experience: Choose a firm with experience in pharmaceutical litigation and MDL cases, not just general personal injury.
- Resources: Pharmaceutical cases require substantial resources for medical experts, document review, and litigation. A firm with a dedicated mass tort team is better equipped.
- Communication: Your attorney should explain the process clearly, answer your questions, and keep you updated on your case status.
- No pressure: A reputable attorney will not pressure you to sign immediately. You should have time to ask questions and consider your options.
- National reach, local presence: Many mass tort firms handle cases nationwide but work with local counsel as needed. Make sure you understand who will handle your case day to day.
Common Mistakes to Avoid
- Waiting too long: The statute of limitations can expire while you are still recovering or deciding what to do.
- Stopping medication without medical advice: Always consult your doctor before changing your treatment.
- Posting about your case on social media: Defense attorneys may review your public posts. Avoid discussing your case, symptoms, or legal strategy online.
- Accepting a quick settlement without legal advice: Early settlement offers may not reflect the full value of your claim, especially if your injuries are ongoing.
- Throwing away evidence: Keep all medication packaging, pharmacy records, and medical documents.
- Signing documents from the manufacturer or insurer without an attorney: Do not sign releases or settlement agreements before consulting a lawyer.
Still Taking Tirzepatide?
If you are currently taking tirzepatide and are concerned about side effects, talk to your prescribing doctor. Do not stop the medication on your own. Your doctor can help you weigh the benefits and risks, monitor for warning signs, and discuss alternatives if appropriate. Warning signs that warrant prompt medical attention include severe or persistent abdominal pain, vomiting that does not resolve, inability to pass stool or gas, severe nausea, and signs of dehydration.
Frequently Asked Questions
Can I file if I stopped taking tirzepatide?
Yes. Many plaintiffs stopped taking the drug after experiencing side effects. Your eligibility depends on whether you can show that tirzepatide caused your injury, not on whether you are still taking it.
What if I took tirzepatide for weight loss, not diabetes?
Both Mounjaro (diabetes) and Zepbound (weight management) contain tirzepatide. Lawsuits cover both uses, as long as you can document your prescription and injury.
Do I need to prove Eli Lilly knew about the risks?
Your attorney will need to present evidence that the manufacturer failed to adequately warn about risks or otherwise acted negligently. This is typically established through internal documents, FDA communications, clinical trial data, and expert testimony — evidence your attorney gathers during discovery.
How long will my case take?
Mass tort cases often take 2 to 4 years from filing to resolution, depending on the progress of the MDL, bellwether trials, and settlement negotiations. Your attorney can give you a more specific estimate based on the current status of the litigation.
Will I have to go to court?
Most pharmaceutical cases settle before trial. However, you should be prepared for the possibility of depositions, medical examinations, and, in rare cases, a trial.
The Bottom Line
Tirzepatide has helped many patients manage diabetes and lose weight, but for some, it has allegedly caused serious, life-altering injuries. If you suffered gastroparesis, intestinal blockage, pancreatitis, gallbladder disease, vision loss, or other severe complications after taking Mounjaro or Zepbound, you may have a legal claim. The first step is to get medical care, preserve your records, and consult a qualified tirzepatide lawyer for a free case evaluation. Time limits apply, so do not delay — protecting your health and your legal rights starts with understanding your options.
Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice. Laws vary by state, and the outcome of any case depends on its specific facts. Consult a licensed attorney in your state and a qualified healthcare provider for advice about your situation.
